Impact of β-Lactamase Inhibition on the Activity of Ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus

被引：36
|
作者：
Dubee, Vincent [1 ,2 ,3 ,4 ]
Soroka, Daria [1 ,2 ,3 ]
Cortes, Melanie [1 ,2 ,3 ]
Lefebvre, Anne-Laure [1 ,2 ,3 ]
Gutmann, Laurent [1 ,2 ,3 ,5 ]
Hugonnet, Jean-Emmanuel [1 ,2 ,3 ]
Arthur, Michel [1 ,2 ,3 ]
Mainardi, Jean-Luc [1 ,2 ,3 ,5 ]
机构：
[1] INSERM, LRMA, Ctr Rech Cordeliers, Equipe 12,UMR S 1138, Paris, France
[2] Univ Paris 06, Sorbonne Univ, Ctr Rech Cordeliers, UMR S 1138, Paris, France
[3] Univ Paris 05, Ctr Rech Cordeliers, Sorbonne Paris Cite, UMR S 1138, Paris, France
[4] Hop St Antoine, AP HP, Serv Reanimat Med, F-75571 Paris, France
[5] Hop Europeen Georges Pompidou, AP HP, Paris, France
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2015年 / 59卷 / 05期
关键词：
MASSILIENSE; CEPHALOSPORIN; INFECTIONS; ACID;
D O I：
10.1128/AAC.05080-14
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The production of beta-lactamases BlaMab and BlaC contributes to beta-lactam resistance in Mycobacterium abscessus and Mycobacterium tuberculosis, respectively. Ceftaroline was efficiently hydrolyzed by these enzymes. Inhibition of M. tuberculosis BlaC by clavulanate decreased the ceftaroline MIC from >= 256 to 16 to 64 mu g/ml, but these values are clinically irrelevant. In contrast, the ceftaroline-avibactam combination should be evaluated against M. abscessus since it inhibited growth at lower and potentially achievable drug concentrations.
引用
收藏
页码：2938 / 2941
页数：4
相关论文
共 50 条
  • [31] Identification of Compounds with pH-Dependent Bactericidal Activity against Mycobacterium tuberculosis
    Early, Julie
    Ollinger, Juliane
    Darby, Crystal
    Alling, Torey
    Mullen, Steven
    Casey, Allen
    Gold, Ben
    Ochoada, Jason
    Wiernicki, Todd
    Masquelin, Thierry
    Nathan, Carl
    Hipskind, Philip A.
    Parish, Tanya
    ACS INFECTIOUS DISEASES, 2019, 5 (02): : 272 - 280
  • [32] Alternate pathway to ascorbate induced inhibition of Mycobacterium tuberculosis
    Shukla, Harish
    Khan, Shaheb Raj
    Shukla, Rohit
    Krishna, Manju Yasoda
    Akhtar, Md Sohail
    Tripathi, Timir
    TUBERCULOSIS, 2018, 111 : 161 - 169
  • [33] Dual β-Lactam Combinations Highly Active against Mycobacterium abscessus Complex In Vitro
    Pandey, R.
    Chen, L.
    Manca, C.
    Jenkins, S.
    Glaser, L.
    Vinnard, C.
    Stone, G.
    Lee, J.
    Mathema, B.
    Nuermberger, E. L.
    Bonomo, R. A.
    Kreiswirth, B. N.
    MBIO, 2019, 10 (01):
  • [34] Synthesis and Characterization of Phenylalanine Amides Active against Mycobacterium abscessus and Other Mycobacteria
    Lang, Markus
    Ganapathy, Uday S.
    Mann, Lea
    Abdelaziz, Rana
    Seidel, Rudiger W.
    Goddard, Richard
    Sequenzia, Ilaria
    Hoenke, Sophie
    Schulze, Philipp
    Aragaw, Wassihun Wedajo
    Csuk, Rene
    Dick, Thomas
    Richter, Adrian
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (07) : 5079 - 5098
  • [35] In vitro antimicrobial activity of doxycycline, minocycline, and tigecycline against Mycobacterium abscessus complex: A meta-analysis study
    Zhang, Weihe
    Dong, Lingling
    Men, Peixuan
    Jiang, Guanglu
    Wang, Fen
    Wang, Congli
    Cheng, Mengli
    Huang, Hairong
    Yu, Xia
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2024, 110 (02)
  • [36] Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus
    Abdalla, Maher Y.
    Switzer, Barbara L.
    Goss, Christopher H.
    Aitken, Moira L.
    Singh, Pradeep K.
    Britigan, Bradley E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (08) : 4826 - 4834
  • [37] Curcumin, an antibiotic resistance breaker against a multiresistant clinical isolate of Mycobacterium abscessus
    Marini, Emanuela
    Di Giulio, Mara
    Magi, Gloria
    Di Lodovico, Silvia
    Cimarelli, Maria Enrica
    Brenciani, Andrea
    Nostro, Antonia
    Cellini, Luigina
    Facinelli, Bruna
    PHYTOTHERAPY RESEARCH, 2018, 32 (03) : 488 - 495
  • [38] High-Throughput Screening Identifies Synthetic Peptides with Antibacterial Activity against Mycobacterium abscessus and Serum Stability
    Iannuzo, Natalie
    Haller, Yannik A.
    McBride, Michelle
    Mehari, Sabrina
    Lainson, John C.
    Diehnelt, Chris W.
    Haydel, Shelley E.
    ACS OMEGA, 2022, : 23967 - 23977
  • [39] Impact of Susceptibility to Injectable Antibiotics on the Treatment Outcomes of Mycobacterium abscessus Pulmonary Disease
    Park, Youngmok
    Park, Yea Eun
    Jhun, Byung Woo
    Park, Jimyung
    Kwak, Nakwon
    Jo, Kyung-Wook
    Yim, Jae-Joon
    Shim, Tae Sun
    Kang, Young Ae
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (06):
  • [40] In Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline against Drug-Resistant Clinical Isolates of Mycobacterium abscessus
    Kaushik, Amit
    Ammerman, Nicole C.
    Martins, Olumide
    Parrish, Nicole M.
    Nuermberger, Eric L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (06)
12345